Roche & Generic Firms Propose SMART-er Accutane Risk Management Program

"Consensus proposal" includes mandatory registration of female patients and prescribers. The proposed enhancements to SMART incorporate aspects of Celgene's STEPS program for Thalomid, but avoid restricted distribution.